Molecular Determinants of the Response of Glioblastomas to EGFR Kinase InhibitorsIngo K. Mellinghoff, Paul S. Mischel, Kan Lu et al.|New England Journal of Medicine|2005Cited by 1.4k
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to gliomaRameen Beroukhim, William R. Sellers, Gad Getz et al.|Proceedings of the National Academy of Sciences|2007Cited by 1.1k
Facet joint pain—advances in patient selection and treatmentSteven P. Cohen, Chad M. Brummett, Julie H. Huang|Nature Reviews Rheumatology|2012Cited by 229